Andrea G Buchwald1, Alick Sixpence2, Mabvuto Chimenya2, Milius Damson2, John D Sorkin3, Mark L Wilson4, Karl Seydel5, Sarah Hochman6, Don P Mathanga2, Terrie E Taylor5, Miriam K Laufer1. 1. Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore. 2. Malaria Alert Center, University of Malawi College of Medicine, Blantyre. 3. Department of Veterans Affairs, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore. 4. Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor. 5. College of Osteopathic Medicine, Michigan State University, East Lansing. 6. Department of Medicine, New York University School of Medicine.
Abstract
Background: Asymptomatic Plasmodium falciparum infections are common in Malawi; however, the implications of these infections for the burden of malaria illness are unknown. Whether asymptomatic infections eventually progress to malaria illness, persist without causing symptoms, or clear spontaneously remains undetermined. We identified asymptomatic infections and evaluated the associations between persistent asymptomatic infections and malaria illness. Methods: Children and adults (N = 120) who presented at a health facility with uncomplicated malaria were followed monthly for 2 years. During follow-up visits, participants with malaria symptoms were tested and, if positive, treated. Samples from all visits were tested for parasites using both microscopy and polymerase chain reaction, and all malaria infections underwent genotyping. Cox frailty models were used to estimate the temporal association between asymptomatic infections and malaria illness episodes. Mixed models were used to estimate the odds of clinical symptoms associated with new versus persistent infections. Results: Participants had a median follow-up time of 720 days. Asymptomatic infections were detected during 23% of visits. Persistent asymptomatic infections were associated with decreased risk of malaria illness in all ages (hazard ratio 0.50, P < .001). When asymptomatic infections preceded malaria illness, newly-acquired infections were detected at 92% of subsequent clinical episodes, independent of presence of persistent infections. Malaria illness among children was more likely due to newly-acquired infections (odds ratio, 1.4; 95% confidence interval, 1.3-1.5) than to persistent infections. Conclusions: Asymptomatic P. falciparum infections are associated with decreased incidence of malaria illness, but do not protect against disease when new infection occurs.
Background: Asymptomatic Plasmodium falciparum infections are common in Malawi; however, the implications of these infections for the burden of malaria illness are unknown. Whether asymptomatic infections eventually progress to malaria illness, persist without causing symptoms, or clear spontaneously remains undetermined. We identified asymptomatic infections and evaluated the associations between persistent asymptomatic infections and malaria illness. Methods:Children and adults (N = 120) who presented at a health facility with uncomplicated malaria were followed monthly for 2 years. During follow-up visits, participants with malaria symptoms were tested and, if positive, treated. Samples from all visits were tested for parasites using both microscopy and polymerase chain reaction, and all malaria infections underwent genotyping. Cox frailty models were used to estimate the temporal association between asymptomatic infections and malaria illness episodes. Mixed models were used to estimate the odds of clinical symptoms associated with new versus persistent infections. Results:Participants had a median follow-up time of 720 days. Asymptomatic infections were detected during 23% of visits. Persistent asymptomatic infections were associated with decreased risk of malaria illness in all ages (hazard ratio 0.50, P < .001). When asymptomatic infections preceded malaria illness, newly-acquired infections were detected at 92% of subsequent clinical episodes, independent of presence of persistent infections. Malaria illness among children was more likely due to newly-acquired infections (odds ratio, 1.4; 95% confidence interval, 1.3-1.5) than to persistent infections. Conclusions: Asymptomatic P. falciparum infections are associated with decreased incidence of malaria illness, but do not protect against disease when new infection occurs.
Authors: Silvia Portugal; Tuan M Tran; Aissata Ongoiba; Aboudramane Bathily; Shanping Li; Safiatou Doumbo; Jeff Skinner; Didier Doumtabe; Younoussou Kone; Jules Sangala; Aarti Jain; D Huw Davies; Christopher Hung; Li Liang; Stacy Ricklefs; Manijeh Vafa Homann; Philip L Felgner; Stephen F Porcella; Anna Färnert; Ogobara K Doumbo; Kassoum Kayentao; Brian M Greenwood; Boubacar Traore; Peter D Crompton Journal: Clin Infect Dis Date: 2017-03-01 Impact factor: 9.079
Authors: S Viriyakosol; N Siripoon; C Petcharapirat; P Petcharapirat; W Jarra; S Thaithong; K N Brown; G Snounou Journal: Bull World Health Organ Date: 1995 Impact factor: 9.408
Authors: Anne-Maria Rantala; Steve M Taylor; Paul A Trottman; Mari Luntamo; Bernard Mbewe; Kenneth Maleta; Teija Kulmala; Per Ashorn; Steven R Meshnick Journal: Malar J Date: 2010-10-06 Impact factor: 2.979
Authors: Sammuel L Nsobya; Sunil Parikh; Fred Kironde; George Lubega; Moses R Kamya; Philip J Rosenthal; Grant Dorsey Journal: J Infect Dis Date: 2004-05-24 Impact factor: 5.226
Authors: Jenna E Coalson; Lauren M Cohee; Andrea G Buchwald; Andrew Nyambalo; John Kubale; Karl B Seydel; Don Mathanga; Terrie E Taylor; Miriam K Laufer; Mark L Wilson Journal: Malar J Date: 2018-04-03 Impact factor: 2.979
Authors: Dominique Earland; Andrea G Buchwald; Alick Sixpence; Mabvuto Chimenya; Milius Damson; Karl B Seydel; Don P Mathanga; Terrie E Taylor; Miriam K Laufer Journal: Am J Trop Med Hyg Date: 2019-08 Impact factor: 2.345
Authors: Andrea G Buchwald; John D Sorkin; Alick Sixpence; Mabvuto Chimenya; Milius Damson; Mark L Wilson; Karl Seydel; Sarah Hochman; Don Mathanga; Terrie E Taylor; Miriam K Laufer Journal: Am J Epidemiol Date: 2019-01-01 Impact factor: 4.897
Authors: Kelsey M Sumner; Elizabeth Freedman; Judith N Mangeni; Andrew A Obala; Lucy Abel; Jessie K Edwards; Michael Emch; Steven R Meshnick; Brian W Pence; Wendy Prudhomme-O'Meara; Steve M Taylor Journal: Clin Infect Dis Date: 2021-10-05 Impact factor: 9.079
Authors: Christopher C Stanley; Lawrence N Kazembe; Andrea G Buchwald; Mavuto Mukaka; Don P Mathanga; Michael G Hudgens; Miriam K Laufer; Tobias F Chirwa Journal: J Med Stat Inform Date: 2019
Authors: Kevin Wamae; Kelvin M Kimenyi; Victor Osoti; Zaydah R de Laurent; Leonard Ndwiga; Oksana Kharabora; Nicholas J Hathaway; Jeffrey A Bailey; Jonathan J Juliano; Philip Bejon; Lynette Isabella Ochola-Oyier Journal: J Infect Dis Date: 2022-09-13 Impact factor: 7.759
Authors: Zalak Shah; Myo T Naung; Kara A Moser; Matthew Adams; Andrea G Buchwald; Ankit Dwivedi; Amed Ouattara; Karl B Seydel; Don P Mathanga; Alyssa E Barry; David Serre; Miriam K Laufer; Joana C Silva; Shannon Takala-Harrison Journal: PLoS Genet Date: 2021-05-25 Impact factor: 5.917
Authors: Zalak Shah; Matthew Adams; Kara A Moser; Biraj Shrestha; Emily M Stucke; Miriam K Laufer; David Serre; Joana C Silva; Shannon Takala-Harrison Journal: Malar J Date: 2020-03-30 Impact factor: 2.979